Diagnostic and Interventional Cardiology

Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
The 34th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF), was held Sept. 16-20 in Boston, MA. For those of us on hand ...
Top 10: Most-read Content in September
Here is a recap of what DAIC viewers found most interesting during the month of September: 1. Unloading with Impella for 30 Minutes Before PCI Associated with Reduced Infarct Size in STEMI Patients 2 ...
Photo Gallery Highlighting TCT 2022
The Photo Gallery includes images taken by DAIC's editorial team at the 34th Transcatheter Cardiovascular Therapeutics (TCT) annual scientific symposium of the Cardiovascular Research Foundation (CRF) ...
Spotlight on Heart Disease Prevention Pioneer, Jeremiah Stamler, MD
World Heart Day takes place each year on September 29. Founded in 2000 by the World Heart Federation, World Heart Day aims to increase awareness of heart disease and stroke worldwide. Our editorial ...

The American Society of Echocardiography (ASE) is targeting its research funding over the next five years to help solve some of the mysteries around the early detection of a common form of heart failure.

American Society of Echocardiography Invests in Joint Research Initiative to Help Patients Suffering from Wide-Reaching Form of Heart Failure

October 5, 2022 — The American Society of Echocardiography (ASE) is targeting its research funding over the next five ...

October 05, 2022

CinCor Pharma, Inc. (NASDAQ: CINC) today announced that the company will present Phase 2 data from its BrigHtn trial evaluating baxdrostat in patients with treatment-resistant hypertension as part of the late-breaking science session

News | Hypertension

CinCor Pharma Announces Late-Breaking Presentation of Phase 2 BrigHtn Data for Baxdrostat in Treatment-Resistant Hypertension at the Upcoming 2022 American Heart Association Scientific Sessions

October 5, 2022 — CinCor Pharma, Inc. (NASDAQ: CINC) today announced that the company will present Phase 2 data from its ...

October 05, 2022

Dr. Rakesh Arora to lead cardiac intensive care units and cardiac surgery research

News | Cardiovascular Business

UH Harrington Heart & Vascular Institute Recruits Renowned Cardiac Surgeon from Canada

October 5, 2022 — University Hospitals (UH) Harrington Heart & Vascular Institute has a rich history of providing the ...

October 05, 2022

Sponsored Content

Blog | ECG

BLOG: Rethinking Traditional ECG Outsourcing

Technology-enabled “Insourcing” approach to cardiac arrhythmia diagnosis provides patient and provider benefits The ...

September 19, 2022

During the Heart Failure Society of America (HFSA) 2022 Scientific Meeting, Daxor Corporation announced new data from multiple studies validating the benefits of the company’s BVA-100 blood test for patients with heart failure.

News | Heart Failure

Blood Volume Measurement Supports Heart Failure Patients, Studies Show

October 5, 2022 — New data presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2022, held ...

October 05, 2022

New analysis adds to growing body of evidence in support of the use of sotagliflozin, an investigational dual SGLT1 and SGLT2 inhibitor, in the treatment of heart failure

News | Heart Failure

New Data Shows Heart Failure Treatment Guided by Daxor’s BVA-100 Lowers Hospital Length of Stay by 55%

October 4, 2022 — Newswise — Daxor Corporation, a global leader in blood volume measurement technology, today announces ...

October 04, 2022

News | Cardiovascular Clinical Studies

New Analysis of Soloist-WHF Trial Underscores Sotagliflozin’s Effect on Reducing Recurrent Heart Failure Events

October 4, 2022 — Lexicon Pharmaceuticals, Inc. announced that a new analysis of results from the SOLOIST-WHF Phase ...

October 04, 2022

Sponsored Content

Several wearable, less-obtrusive ECG monitors fhave been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device.

Blog | ECG

BLOG: Moving Beyond Holter ECG: The Rise in Next Generation Technology

When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...

August 24, 2022

12 month data from The PRECISE Trial, the first global, prospective, randomized trial comparing diagnosis and evaluation pathways for stable chest pain, will be presented at the AHA 2022 Scientific Sessions.

News | AHA

HeartFlow Announces Late Breakers Presentation at the 2022 American Heart Association (AHA) Scientific Sessions

October 4, 2022 — HeartFlow, Inc., the leader in revolutionizing precision heart care, announced that the results of the ...

October 04, 2022

The stage is set for the American Heart Association (AHA) Scientific Sessions 2022, to be held November 5-7 at McCormick Place in Chicago, and virtually.

News | AHA

AHA Scientific Sessions 2022 Program, Late-breakers Announced

October 4, 2022 — The American Heart Association (AHA) Scientific Sessions 2022 is set for November 5-7 at McCormick ...

October 04, 2022

The World Connect Theater at TCT 2022 hosted dozens of panel discussions joining global cardiovascular specialists sharing scientific breakthroughs to large and attentive audiences throughout the Sept. 16-20 event in Boston, MA.

Feature | TCT | By Christine Book

Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review

The 34th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research ...

October 03, 2022

Sponsored Content

OTC ECG devices can help detect abnormal heart rhythms in the general population, and this technology will continue to improve.

Blog | ECG

BLOG: A Double-Edged Sword: How Over-the-Counter ECG Devices are Impacting Cardiac Care

Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness ...

August 24, 2022

The Impella CP with SmartAssist heart pump is a minimally invasive, temporary heart pump that uses real-time intelligence associated with improved survival and heart recovery. (Graphic: Business Wire)

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Top 10: Most-read Content in September

Here is a recap of what DAIC viewers found most interesting during the month of September: 1. Unloading with Impella for ...

October 03, 2022

Presentations highlight the significant potential clinical benefits of managing congestion in patients with heart failure with FUROSCIX (furosemide injection) at home

News | Heart Failure

scPharmaceuticals Announces Data Presentations at the Heart Failure Society of America 2022 Annual Scientific Meeting

October 3, 2022 — scPharmaceuticals Inc., a pharmaceutical company focused on developing and commercializing products ...

October 03, 2022

The first-of-its-kind patch, designed to offer comfort and free movement, provides actionable reports in under 24 hours to revolutionize the detection of conditions that cost the United States $363bn annually, allowing medical institutions to save more lives and scale their practice

News | Wearables

Mawi launches Mawi Heart Patch

October 3, 2022 — Mawi, creators of AI-powered wearable medical devices for cardiac disease diagnostic and monitoring ...

October 03, 2022

Sponsored Content

The ECG data is automatically analyzed by the Cardea SOLO software and an easy to read and interpret report is generated in five minutes.

Blog | Wearables

BLOG: Cardiac Monitoring in the Time of COVID-19: Next Generation Wearable ECG Technology Comes into Its Own

COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office ...

August 24, 2022

The new ECHO lab enables cardiac teams to use ultrasound (or echocardiography) to assess the size and efficiency of heart chambers. Stress tests, coronary CTAs, and cardiac MRIs are also interpreted there.

News | Congenital Heart

Memorial Cardiac and Vascular Institute Battling Heart Disease in a New Place

October 3, 2022 — A new ‘ECHO lab’ at Memorial Hospital West is benefiting patients that may have heart disease and the ...

October 03, 2022

The Transcatheter Cardiovascular Therapeutics (TCT) conference, which is the Cardiovascular Research Foundation's (CRF) annual scientific symposium and one of the world's foremost educational forum specializing in interventional cardiovascular medicine, is marking its 34th year in 2022, from September 16-19 in Boston, returning to its pre-pandemic format.

Gallery | TCT | By Melinda Taschetta-Millane and Christine Book

Photo Gallery Highlighting TCT 2022

The Photo Gallery includes images taken by DAIC's editorial team at the 34th Transcatheter Cardiovascular Therapeutics ...

October 03, 2022

News | ECG

HeartBeam Granted Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)

September 29, 2022 — HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ECG ...

September 29, 2022